Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  MannKind Corporation    

MANNKIND CORPORATION
Mes dernières consult.
Most popular
  Report  
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

MannKind Corporation : MNKD, MU, ALXN and GMCR added to NASDAQ Active Stock Watch List at EPR

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/16/2013 | 03:05pm CEST

New York, NY - (ACCESSWIRE) - 07/16/2013 - Equity Profile Report initiates its NASDAQ Active Stock Watch List adding MannKind Corp. (NASDAQ:MNKD), Micron Technology Inc. (NASDAQ:MU), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Green Mountain Coffee Roasters, Inc. (NASDAQ:GMCR),

MannKind Corp. (NASDAQ:MNKD) a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States closed up in its previous session (+6.47%) on 7,469,136 shares traded. MannKind Corp. (NASDAQ:MNKD) is currently up (+310.99%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about MannKind Corp. (NASDAQ:MNKD)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=MNKD&SubId=AW

Micron Technology Inc. (NASDAQ:MU) a company that together with its subsidiaries, engages in manufacturing and marketing semiconductor devices worldwide closed up in its previous session (+2.99%) on 29,731,748 shares traded after Micron Technology Inc reported its Financials. Micron Technology Inc. (NASDAQ:MU) is currently up (+155.62%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about Micron Technology Inc. (NASDAQ:MU)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=MU&SubId=AW

Also mentioned in Equity Profile Report?s NASDAQ Active Stock Watch List and Investor Poll was: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Green Mountain Coffee Roasters, Inc. (NASDAQ:GMCR), Groupon, Inc. (NASDAQ:GRPN) and Zynga, Inc. (NASDAQ:ZNGA)

To see what other investors are saying about: ALXN, GMCR, GRPN, ZNGA

Click here: http://www.equityprofilereport.com/PR.aspx?stock=ALXN-GMCR-GRPN-ZNGA&SubId=AW

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed. Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:

Equity Profile Report

[email protected]


© Accesswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MANNKIND CORPORATION
05/18MANNKIND CORPORATION (NASDAQ : MNKD) Files An 8-K Submission of Matters to a Vot..
AQ
05/17MANNKIND CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/10CIPLA : to market Afrezza, an inhaled insulin in India
AQ
05/09MANNKIND : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
05/09MANNKIND : 1Q Earnings Snapshot
AQ
05/09MANNKIND CORP : Results of Operations and Financial Condition (form 8-K)
AQ
05/09MannKind Corporation Reports 2018 First Quarter Financial Results
GL
05/09MannKind and Cipla Enter an Exclusive Marketing and Distribution Agreement fo..
GL
05/02MANNKIND : to Hold 2018 First Quarter Financial Results Conference Call on May 9..
AQ
04/26MANNKIND : Patent Issued for Formation of N-Protected Bis-3,6-(4-Aminobutyl)-2, ..
AQ
More news
News from SeekingAlpha
2017Midday Gainers / Losers 
2017HEALTHCARE - TOP GAINERS / LOSERS AS : 00 am 
2017MannKind - Afrezza Sales Struggle As February Comes To A Close 
2017MANNKIND ENACTS REVERSE SPLIT AT 1-F : What Investors Need To Consider 
2017Post-split trading in MannKind commences today 
Financials ($)
Sales 2018 23,3 M
EBIT 2018 -96,9 M
Net income 2018 -99,5 M
Debt 2018 -
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales 2018 12,0x
Capi. / Sales 2019 6,79x
Capitalization 279 M
Technical analysis trends MANNKIND CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
 
Mean consensus HOLD
Number of Analysts 2
Average target price 3,00 $
Spread / Average Target 50%
EPS Revisions
Managers
NameTitle
Michael E. Castagna Chief Executive Officer & Director
Kent Kresa Chairman
Steven Binder Chief Financial & Accounting Officer
Joseph Kocinsky Chief Technology Officer & Vice President
David M. Kendall Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
MANNKIND CORPORATION279
GILEAD SCIENCES-5.05%88 140
VERTEX PHARMACEUTICALS4.08%39 840
REGENERON PHARMACEUTICALS-18.08%32 633
GENMAB23.23%12 171
BEIGENE LTD (ADR)99.09%10 130